| 1.10 Delayed Data As of Nov 16 |  -0.04 / -3.51%Today’s Change | 1.10 Today|||52-Week Range 9.05 | -84.51% Year-to-Date |
| Previous close | 1.14 |
| Today’s open | 1.14 |
| Day’s range | 1.10 - 1.14 |
| Volume | 138,235 |
| Average volume (3 months) | 127,482 |
| Market cap | $39.5M |
| Earnings growth (last year) | +42.19% |
| Earnings growth (this year) | -67.57% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 14.03 |
| Price/Book | 0.59 |
| Today’s change | Today’s % change | |
|---|---|---|
| ICCCImmuCell Corp | -0.01 | -0.15% |
| CLBSCaladrius Bioscience... | -0.13 | -2.63% |
| AZRXAzurRx BioPharma Inc | -0.04 | -1.75% |
| CRISCuris Inc | +0.03 | +2.07% |
| Next reporting date | November 20, 2018 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $13.9M |
| Annual profit (last year) | -$10.1M |
| Net profit margin | -73.12% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Dror Harats |
Vice President-Research & Operations Eyal Breitbart |
Corporate headquarters Modi'in, Jerusalem |
